Stocky turns companies like Alibaba Health Information Tech into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.
Try Stocky free →Cautious. ALBBY scores below-average on growth (40.4) and value (32), with Leadership Alignment weak at 36.3—suggesting limited founder conviction or significant dilution. The Vulnerability Index of 50 indicates adequate but not robust financial cushion against downturns. Without pricing power, margin expansion, or clear competitive advantages, the risk/reward is unfavorable for new buyers.
Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for Alibaba Health Information Tech:
Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 41/100, you know instantly whether to dig deeper or skip.
Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.
Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.
Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.
Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.
Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.
Stocky rates Alibaba Health Information Tech (ALBBY) at 41/100 — below the bar Stocky looks for. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Cautious. ALBBY scores below-average on growth (40.4) and value (32), with Leadership Alignment weak at 36.3—suggesting limited founder conviction or significant dilution. The Vulnerability Index of 50 indicates adequate but not robust fina
ALBBY's current Stocky Verdict is 41/100, placing it in the "Cautious" band. This composite combines a 37/100 Compounder score, 36/100 Leadership, Moat rating, and analyst signal.
Stocky hasn't finalised a Moat Score for Alibaba Health Information Tech yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.
Alibaba Health Information Tech scores 36/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.
Alibaba Health Information Tech's Vulnerability Profile scores 50/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to Alibaba Health Information Tech.
Sign up free and unlock the full analysis on ALBBY — the same tools professional analysts use, personalised to your portfolio:
Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.
This page is just a preview. Open the live, interactive version for the full picture:
Or jump straight to the interactive dashboard for ALBBY in the app.
